China orphan drug
May 16, 2017
Novartis, slammed by Korean scandal; FDA tweaks; Dendreon eyes; Amgen adds
Novartis, slammed by Korean scandal, tweaks its ethics, compliance policies Rocked by a corruption scandal in Korea and facing a kickbacks probe in Greece, Novartis says it's strengthening and simplifying its global ethics and compliance approach. The Swiss drug giant is aiming to shift from policing to coaching, wi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
